Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Sci. STKE, 20 January 2004
Vol. 2004, Issue 216, p. re2
[DOI: 10.1126/stke.2162004re2]

REVIEWS

G Proteins in Cancer: The Prostate Cancer Paradigm

Yehia Daaka*

Department of Surgery and Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

Abstract: Signal transduction research investigating mechanisms of androgen-independent prostate cancer cell proliferation has historically focused on the role of androgen and peptide growth factor receptors. More recent work has raised the idea that intracellular signaling mechanisms triggered by extracellular hormonal factors acting through heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) can also mediate and sustain this pathologic process. Prostate cancer patients with advanced disease express elevated levels of GPCRs and GPCR ligands, suggesting that the GPCR system is activated in the cancerous gland and may contribute to tumor growth. Importantly, inhibition of G protein signaling attenuates prostate cancer cell growth in animal models. The nature of intracellular signaling pathways mediating mitogenic effects of GPCRs in prostate cancer is poorly defined, although the G protein-dependent activation of the Ras-to-mitogen-activated protein kinase pathway has emerged as a critical regulatory event. Activated GPCRs may also exert their mitogenic effects in the prostate by activating the androgen receptor.

Contact information. DUMC 2607, Duke University Medical Center, Durham, NC 27710, USA. Telephone, 919-684-8440; fax, 919-684-9990; e-mail, daaka001{at}mc.duke.edu

Citation: Y. Daaka, G Proteins in Cancer: The Prostate Cancer Paradigm. Sci. STKE 2004, re2 (2004).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
2,2-Bis(4-Chlorophenyl)-1,1-Dichloroethylene Stimulates Androgen Independence in Prostate Cancer Cells through Combinatorial Activation of Mutant Androgen Receptor and Mitogen-Activated Protein Kinase Pathways.
S. Shah, J. K. Hess-Wilson, S. Webb, H. Daly, S. Godoy-Tundidor, J. Kim, J. Boldison, Y. Daaka, and K. E. Knudsen (2008)
Mol. Cancer Res. 6, 1507-1520
   Abstract »    Full Text »    PDF »
Vasoactive Intestinal Peptide Transactivates the Androgen Receptor through a Protein Kinase A-Dependent Extracellular Signal-Regulated Kinase Pathway in Prostate Cancer LNCaP Cells.
Y. Xie, D. W. Wolff, M.-F. Lin, and Y. Tu (2007)
Mol. Pharmacol. 72, 73-85
   Abstract »    Full Text »    PDF »
Ligand Binding to the Androgen Receptor Induces Conformational Changes That Regulate Phosphatase Interactions.
C.-S. Yang, H.-W. Xin, J. B. Kelley, A. Spencer, D. L. Brautigan, and B. M. Paschal (2007)
Mol. Cell. Biol. 27, 3390-3404
   Abstract »    Full Text »    PDF »
Differential targeting of Gbetagamma-subunit signaling with small molecules..
T. M. Bonacci, J. L. Mathews, C. Yuan, D. M. Lehmann, S. Malik, D. Wu, J. L. Font, J. M. Bidlack, and A. V. Smrcka (2006)
Science 312, 443-446
   Abstract »    Full Text »    PDF »
Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy.
M. F. McCarty (2004)
Integr Cancer Ther 3, 349-380
   Abstract »    PDF »
Finding fusion genes resulting from chromosome rearrangement by analyzing the expressed sequence databases.
Y. Hahn, T. K. Bera, K. Gehlhaus, I. R. Kirsch, I. H. Pastan, and B. Lee (2004)
PNAS 101, 13257-13261
   Abstract »    Full Text »    PDF »

ADVERTISEMENT
Click Me!

ADVERTISEMENT

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (pre-2008: Science's STKE. ISSN 1525-8882)